Oxford/AstraZeneca vaccine against COVID-19 applies for registration in Ukraine
Oxford/AstraZeneca vaccine against coronavirus (COVID-19) has been submitted for registration in Ukraine under the obligation for emergency medical use.
According to the Center for Public Health website, an application for registration was submitted to the State Expert Center of the Health Ministry on Monday, February 15.
On the same day, WHO approved the AstraZeneca emergency vaccine and gave the green light for use of this vaccine worldwide through the COVAX initiative. The Oxford/AstraZeneca vaccine has previously been approved for emergency use in the UK, European Union and India.
The vaccine will be purchased for public funds directly from manufacturers. It is expected that at least 500,000 doses of the AstraZeneca vaccine will be supplied to Ukraine in February 2021.
As reported, Ukraine received information from COVAX on the supply of vaccines from the manufacturer Oxford/AstraZeneca in the amount of 2.2 to 3.7 million doses in the first or second quarter of 2021.
